Drug Approval | February 14, 2022
Zydus gets 180 days of shared exclusivity for Roflumilast tablets
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
Key takeaways of recent quarter & conference call highlights
Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin
Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified
_256_384.jpg){kind=logo}
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
Adds five years of market exclusivity on approval
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
Subscribe To Our Newsletter & Stay Updated
